37
Views
26
CrossRef citations to date
0
Altmetric
Original Article

Parameters Controlling Topical Delivery of Oligonucleotides by Electroporation

, &
Pages 275-289 | Received 03 Jan 1997, Accepted 15 Apr 1997, Published online: 26 Jun 2009

References

  • Akhtar S., Kole R., Juliano L. Stability of antisense DNA oligodeoxynucleotides analogs in cellular extracts and sera. Life Sciences 1991; 49: 1793–1801
  • Bazile D., Mir L., Paoletti C. Voltage dependant introduction of a d[α]octothymidilate into electropermeabilized cells. Biochem. Biophys. Res. Commun. 1989; 159: 633–639
  • Belehradek J., Jr, Orlowski S., Ramirez L. H., Pron G., Poddevin B., Mir L. M. Electropermeabilization of cells in tissues assessed by the qualitative and quantitative electroloading of bleomycin. Biochim. Biophys. Acta. 1994; 1190: 155–163
  • Bergan R., Connell Y., Fahmy B., Neckers L. Electroporation enhances c-myc antisense oligodeoxynucleotide efficacy. Nucleic. Acids. Res. 1993; 21: 3567–3573
  • Bommannan D. B., Tamada J., Leung L., Potts R. Effect of electroporation on transdermal iontophoretic delivery of luteinising hormone releasing hormone (LHRH) in vitro. Pharm. Res. 1994; 11: 1809–1814
  • Brand R., Iversen P. Iontophoretic delivery of a telomeric oligonucleotide. Pharm. Res. 1996; 13: 851–854
  • Crooke S. The future of antisense technology. Pharm. News 1995; 2: 8–11
  • Crooke S., Bennett C. F. Progress in antisense oligonucleotide therapeutic. Annu. Pharmacol. Toxicol. 1996; 36: 107–129
  • Edwards D. A., Prausnitz M. R., Langer R., Weaver J. C. Analysis of enhanced transdermal transport by skin electroporation. J. Control. Rel. 1995; 34: 211–221
  • Fynan E. F., Webster R. G., Fuller D. H., Haynes J. R., Santoro J. C., Robinson H. L. DNA vaccines: protective immunizations by parenteral, mucosal, and gene-gun inoculations. Proc. Natl. Acad. Sci. USA. 1993; 90: 11478–11482
  • Gillardon F., Eschenfelder C., Uhlmann E., Hartschuh W., Zimmermann M. Differential regulation of c-fos, c-jun, bcl-2 and bax expression in rat skin following single or chronic ultraviolet irradiation and in vivo modulation by antisense oligodeoxynucleotide superfusion. Oncogene 1994; 9: 3219–3225
  • Goodchild J. Inhibition of gene expression by antisense oligonucleotides. Oligonucleotides: Anti-sense Inhibitors of Gene Expression, J. S. Cohen. CRC Press, Boca Raton 1989; 53–77
  • Graham M. J., Freier S. M., Crooke R. M., Eckler D. J., Maslova R. N., Lesnik E. A. Tritium labelling of antisense oligonucleotides by exchange with tritiated water. Nucleic Acids. Res. 1993; 21: 3737–3743
  • Heller R., Jaroszeski M., Glass L., Messina J., Rapaport D., Deconti R., Fenske N., Gilbert R., Mir L., Reintgen D. Phase I/II trial for the treatment of cutaneous and subcutaneous tumors using electrochemotherapy. Cancer 1996; 77: 964–971
  • Jadoul A. Skin perturbations induced by iontophoresis and electroporation: enhancement in drug transport and integrity of the stratum corneum. Université Catholique de Louvain, BrusselsBelgium 1997, PhD. Thesis
  • Marks R., Barton S. P. The significance of the size and shape of corneocytes. Stratum corneum, R. Maecks, G. Plewig. Springer verlag, Berlin 1983; 161–170
  • Nolen H. W., III, Catz P., Friend D. R. Percutaneous penetration of methyl phosphonate antisense oligonucleotides. Int. J. Pharm. 1994; 107: 169–177
  • Oldenburgh K. R., Vo K. T., Smith G. A., Selick H. E. Iontophoretic delivery of oligonucleotides across full thickness hairless mouse skin. J. Pharm. Sci. 1995; 84: 915–921
  • Pinkus I. Anatomy and embryology of the skin. Cancer of the Skin, R. Andrade. Saunders press, Philadelphia 1976; 16–89
  • Pliquett U., Weaver J. C. Electroporation of human skin: simultaneous measurement of changes in the transport of two fluorescent molecules and in the passive electrical properties. Bioelectrochem. Bioenerg. 1996; 39: 1–12
  • Prausnitz M., Bose V., Langer R., Weaver J. Electroporation of mammalian skin: a mechanism to enhance transdermal drug delivery. Proc. Nat. Acad. Sci. USA. 1993; 90: 10504–10508
  • Prausnitz M. R., Pliquett U., Langer R., Weaver J. C. Rapid temporal control of transdermal drug delivery by electroporation. Pharm. Res. 1994; 11: 1834–1837
  • Prausnitz M. R., Edelman E. R., Gimm J. A., Langer R., Weaver J. C. Transdermal Delivery of Heparin by Skin Electroporation. Bio-Technology 1995; 13: 1205–1209
  • Prausnitz M. Transdermal transport efficiency during skin electroporation and iontophoresis. J. Control. Rel. 1996; 38: 205–217
  • Regnier V., Le Doan T., Laurent M., Préat V. Cutaneous delivery of oligonucleotides by electroporation. Pharm. Res. 1996; 13: S383
  • Roizman B. Inhibition of Herpesviridae infection by antisense oligonucleotides. 1992, PCT WO 92/03051
  • Rojanasakul Y. Antisense oligonucleotide therapeutics: drug delivery and targeting. Adv. Drug Del. Rev. 1996; 18: 115–131
  • Rols M. P., Teissiè J. Electropermeabilization of mammalian cells: quantitative analysis of the phenomenon. Biophys. J. 1990; 58: 1089–1098
  • Sambrook J., Fritsch E. F., Maniatis T. Molecular cloning: A laboratory manual. Cold Spring Harbor Laboratory Press, New-York 1989; B16
  • Shin B. C., Lee H. B. Iontophoretic delivery of insulin: effects of skin treatments. Proceed. Int. Symp. Control. Rel. Bioact. Mater. 1994; 21: 373–374
  • Thysman S., Préat V., Roland M. Factors affecting iontophoretic mobility of metoprolol. J. Pharm. Sci. 1991; 81: 670–675
  • Titomirov A. V., Sukharev S., Kistanova E. In vivo electroporation and stable transformation of skin cells of newborn mice by plasmid DNA. Biochim. Biophys. Acta. 1991; 1088: 131–134
  • Tojo K., Chiang C., Doshi U., Chien Y. W. Stratum corneum reservoir capacity affecting dynamics of transdermal drug delivery. Drug Dev. & Ind. Pharm. 1988; 14: 561–572
  • Vanbever R., Lecouturier N., Préat V. Transdermal delivery of metoprolol by electroporation. Pharm. Res. 1994; 11: 1657–1662
  • Vanbever R., Préat V. Factors affecting transdermal delivery of metoprolol by electroporation. Bioelectrochem. Bioenerget. 1995; 38: 223–228
  • Vanbever R., Le Boulangé E., Préat V. Transdermal delivery of fentanyl by electroporation I. Influence of electrical factors. Pharm. Res. 1996a; 13: 557–563
  • Vanbever R., De Morre N., Préat V. Transdermal delivery of fentanyl by electroporation II. Mechanisms involved in drug transport. Pham. Res. 1996b; 13: 1360–1366
  • Vanbever R. Skin electroporation for transdermal drugdelivery. Université Catholique de Louvain, BrusselsBelgium 1997, PhD. Thesis
  • Vlassov V., Nechaeva M., Karamyshev V., Yakubov L. Iontophoretic delivery of oligonucleotide derivatives into mouse tumor. Antisense Res. Dev. 1994; 4: 291–293
  • Weaver J. Electroporation theory. Concepts and mechanisms. Methods. Mol. Biol. 1995; 47: 1–26
  • Weaver J., Chizmadzhev Y. Electroporation. CRC Handbook of biological effects of electromagnetic fields, Second Edition, C. Polk, E. Postow. CRC Press, Boca Raton 1996; 247–274
  • Zewert T. E., Pliquett U. F., Langer R., Weaver J. C. Transdermal transport of DNA antisense oligonucleotides by electroporation. Biochem. Biophys. Res. Commun. 1995; 212: 286–292
  • Zhang L., Li L., Hoffmann G. A., Hoffman R. M. Depth-targeted efficient gene delivery and expression in the skin by pulsed electric fields: an approach to gene therapy of skin ageing and other diseases. Biochem. Biophys. Res. Commun. 1996; 220: 633–636

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.